NFE2L2 and leukemia: These results suggest that, depending on leukemia cell type, the combination of AZD0364 and ZSTK474 shows its pro-apoptotic effect by decreasing or increasing some cytoprotective and regulatory proteins, including NRF2, HO-1, and TrxR.